Russell Investments Group
HUMA icon

Russell Investments Group’s Humacyte HUMA Stock Holding History

Russell Investments Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19K Sell
2,805
-8,374
-75% -$7.76K ﹤0.01% 4111
2026
Q1 		$6.78K Buy
11,179
+479
+4% +$498 ﹤0.01% 3850
2025
Q4 		$10.3K Buy
10,700
+230
+2% +$326 ﹤0.01% 3792
2025
Q3 		$18.2K Buy
+10,470
New +$20.5K ﹤0.01% 3617
2024
Q4 		– Sell
-35
Closed -$190 – 3742
2024
Q3 		$190 Sell
35
-343
-91% -$2.26K ﹤0.01% 3637
2024
Q2 		$1.81K Buy
+378
New +$1.97K ﹤0.01% 3364

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
CFM
Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return

Russell Investments Group's HUMA Position: Q2 2026 in Review

Russell Investments Group reduced its Humacyte (HUMA) stake by 75% in Q2 2026, selling an estimated $7.76K and leaving 2,805 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #4111.

Russell Investments Group first reported a position in HUMA in Q2 2024 and has held it in 6 quarters since. The position peaked at $18.2K in Q3 2025. 72 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Russell Investments Group held 2,805 shares of Humacyte worth $2.19K as of Q2 2026.
  • Russell Investments Group sold 8,374 Humacyte shares in Q2 2026, an estimated $7.76K.
  • Humacyte made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4111 holding.
  • Russell Investments Group first reported a position in Humacyte in Q2 2024 and has held it in 6 quarters since.
  • Russell Investments Group's Humacyte position peaked at $18.2K in Q3 2025.
  • 72 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.